Search

Your search keyword '"Drug Resistance, Multiple, Viral drug effects"' showing total 9 results
Start Over Descriptor "Drug Resistance, Multiple, Viral drug effects" Publisher springer
9 results on '"Drug Resistance, Multiple, Viral drug effects"'

1. [Strategies for combating resistances in HIV therapy--an exemplifying case].

Author

Stoehr A

Subjects
Aged, Anti-HIV Agents adverse effects, CD4 Lymphocyte Count, Clinical Trials, Phase III as Topic, Drug Therapy, Combination, Enfuvirtide, HIV Envelope Protein gp41 adverse effects, HIV Fusion Inhibitors adverse effects, HIV Infections virology, Humans, Long-Term Care, Male, Peptide Fragments adverse effects, Viral Load, Anti-HIV Agents therapeutic use, Drug Resistance, Multiple, Viral drug effects, HIV Envelope Protein gp41 therapeutic use, HIV Fusion Inhibitors therapeutic use, HIV Infections drug therapy, HIV-1 drug effects, Peptide Fragments therapeutic use
Published
2004

2. [New protease inhibitor for PI pretreated patients. Tipranavir targets also multiresistant viruses].

Subjects
CD4 Lymphocyte Count, Delayed-Action Preparations, Dose-Response Relationship, Drug, HIV Infections virology, HIV Protease Inhibitors adverse effects, Humans, Pyridines adverse effects, Pyrones adverse effects, Sulfonamides, Treatment Outcome, Viral Load, Drug Resistance, Multiple, Viral drug effects, HIV Infections drug therapy, HIV Protease Inhibitors therapeutic use, HIV-1 drug effects, Pyridines therapeutic use, Pyrones therapeutic use
Published
2004

3. [Determination of serum levels of antiretroviral drugs].

Author

Kurowski M

Subjects
Anti-HIV Agents adverse effects, Anti-HIV Agents therapeutic use, Anti-Retroviral Agents adverse effects, Anti-Retroviral Agents therapeutic use, Biological Availability, Dose-Response Relationship, Drug, Drug Interactions, Drug Resistance, Multiple, Viral drug effects, HIV Infections drug therapy, HIV-1 drug effects, Humans, Metabolic Clearance Rate physiology, Anti-HIV Agents pharmacokinetics, Anti-Retroviral Agents pharmacokinetics, Drug Monitoring, HIV Infections blood
Published
2004

4. [Maintaining independence. New protease inhibitor receives drug approval recommendation].

Subjects
Carbamates, Clinical Trials as Topic, Drug Administration Schedule, Drug Resistance, Multiple, Viral drug effects, Drug Therapy, Combination, Europe, Furans, HIV Infections virology, HIV Protease Inhibitors adverse effects, Humans, Organophosphates adverse effects, Sulfonamides adverse effects, Viral Load, Drug Approval legislation & jurisprudence, HIV Infections drug therapy, HIV Protease Inhibitors therapeutic use, HIV-1 drug effects, Organophosphates therapeutic use, Sulfonamides therapeutic use
Published
2004

5. [Report from San Francisco. An excerpt of the 11th Retrovirus Conference 2004].

Author

Oette M

Subjects
Anti-HIV Agents adverse effects, Comorbidity, Drug Resistance, Multiple, Viral drug effects, Drug Therapy, Combination, Humans, Randomized Controlled Trials as Topic, San Francisco, AIDS-Related Opportunistic Infections drug therapy, Acquired Immunodeficiency Syndrome drug therapy, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, HIV-1 drug effects, Opportunistic Infections drug therapy
Published
2004

6. [Confirmed NRTI remains an important therapy option. Didanosine effective despite multiple resistance to NRTIs].

Subjects
Didanosine adverse effects, HIV Infections virology, Humans, Randomized Controlled Trials as Topic, Reverse Transcriptase Inhibitors adverse effects, Treatment Outcome, Viral Load classification, Didanosine therapeutic use, Drug Resistance, Multiple, Viral drug effects, HIV Infections drug therapy, HIV-1 drug effects, Reverse Transcriptase Inhibitors therapeutic use
Published
2004

7. [Resistance in a new light. About mutations and their interactions].

Subjects
Adenine adverse effects, Anti-HIV Agents adverse effects, Drug Resistance, Multiple, Viral drug effects, HIV-1 drug effects, Humans, Microbial Sensitivity Tests, Mutagenesis drug effects, Organophosphorus Compounds adverse effects, Tenofovir, Treatment Outcome, Virus Replication drug effects, Virus Replication genetics, Acquired Immunodeficiency Syndrome drug therapy, Acquired Immunodeficiency Syndrome virology, Adenine administration & dosage, Adenine analogs & derivatives, Anti-HIV Agents administration & dosage, Drug Resistance, Multiple, Viral genetics, HIV-1 genetics, Mutagenesis genetics, Organophosphonates, Organophosphorus Compounds administration & dosage
Published
2003

8. ["Double boosting" passes the test. LPV/r plus SQV in complicated salvage situation].

Subjects
Clinical Trials as Topic, Cohort Studies, Drug Synergism, Germany, HIV Protease Inhibitors adverse effects, Humans, Lopinavir, Pyrimidinones adverse effects, Ritonavir adverse effects, Saquinavir adverse effects, Acquired Immunodeficiency Syndrome drug therapy, Drug Resistance, Multiple, Viral drug effects, HIV Protease Inhibitors administration & dosage, Pyrimidinones administration & dosage, Ritonavir administration & dosage, Salvage Therapy, Saquinavir administration & dosage
Published
2003

9. [Non-peptide protease inhibitor in phase III study. Tipranavir--control of multidrug resistant viruses].

Subjects
Acquired Immunodeficiency Syndrome virology, Dose-Response Relationship, Drug, Drug Therapy, Combination, HIV Protease Inhibitors adverse effects, Humans, Multicenter Studies as Topic, Pyridines adverse effects, Pyrones adverse effects, Randomized Controlled Trials as Topic, Sulfonamides, Virus Replication drug effects, Acquired Immunodeficiency Syndrome drug therapy, Drug Resistance, Multiple, Viral drug effects, HIV Protease Inhibitors administration & dosage, HIV-1 drug effects, Pyridines administration & dosage, Pyrones administration & dosage
Published
2003

Catalog

Books, media, physical & digital resources
See catalog results